These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. An update on the diagnosis and treatment of leprosy. Moschella SL. J Am Acad Dermatol; 2004 Sep; 51(3):417-26. PubMed ID: 15337986 [No Abstract] [Full Text] [Related]
5. Treatment of leprosy in the United States. Levis WR. Bull N Y Acad Med; 1984 Sep; 60(7):696-711. PubMed ID: 6386081 [No Abstract] [Full Text] [Related]
6. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy. Narang T, Kaur I, Kumar B, Radotra BD, Dogra S. Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):105-14. PubMed ID: 16830653 [Abstract] [Full Text] [Related]
7. A relic that disturbs. Chaturvedi S, Sharma AL. Indian J Public Health; 2003 Jun; 47(4):151-3. PubMed ID: 15125555 [No Abstract] [Full Text] [Related]
12. Second coming: the re-emergence and modernization of immunotherapy by vaccines as a component of leprosy control. Duthie MS, Casper C, Reed SG. Future Microbiol; 2018 Oct; 13():1449-1451. PubMed ID: 30311780 [No Abstract] [Full Text] [Related]
14. Impact of multidrug therapy on the treatment and control of leprosy. Chatterjee BR. Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):271-2. PubMed ID: 1482479 [No Abstract] [Full Text] [Related]
15. BCG vaccination in leprosy. Price JE. Int J Lepr Other Mycobact Dis; 1982 Jun; 50(2):205-12. PubMed ID: 6749707 [No Abstract] [Full Text] [Related]
16. Investigations related to the development of a leprosy vaccine. Convit J, Aranzazu N, Ulrich M, Zúñiga M, de Aragón ME, Alvarado J, Reyes O. Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):531-9. PubMed ID: 6231259 [No Abstract] [Full Text] [Related]